CHA Biotech

085660 · KOSDAQ · Health Care · SMALL CAP

Updated terms.

CHA Biotech updated the disclosed terms of an acquisition of CHA Healthcare Co., Ltd., now worth US$99.5M.

M&A([Amended] Decision to acquire shares/equity in another company)· FILED 2026-06-26· RCEPT 20260626901433

US$99.5MDeal value
6.0%vs. company assets

Converted at 1 USD ≈ ₩1,546.48 (filing-date rate, 2026-06-25 close)

What happened

CHA Biotech updated the disclosed terms of an acquisition of CHA Healthcare Co., Ltd., now worth US$99.5M.

For context, this deal is worth about 6.0% of the company's own total assets.

TargetCHA Healthcare Co., Ltd.
Deal valueUS$99.5M
vs. company assets6.0%
Filed2026-06-26, [Amended] Decision to acquire shares/equity in another company
SourceDART rcept 20260626901433 → open original filing

Versions of this filing

  1. 2026-06-26Original
  2. 2026-06-26Amendment 1 (this page)

Source: DART. Information only, not investment advice.

For informational purposes only. This is not investment advice, a recommendation, or a solicitation to buy or sell any security. Do your own research; any investment decision is your own responsibility.

Data from DART, Korea's official corporate-filing system. Data sourced from official DART filings. Accuracy is not guaranteed. Figures are as of the date shown. As of 2026-06-26 (KST). · Converted at 1 USD ≈ ₩1,325 (rate of 2026-10-21).

Company summaries are generated and may contain errors; financial figures are mapped directly from official filings.